lobbying_activities: 2674595

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2674595	2eaa7409-ae49-4759-bb0c-ae867d99d97a	Q3	CARLOW CONSULTING, LLC	401104840	SCHOOL EMPLOYEES RETIREMENT SYSTEM OF OHIO	2021	third_quarter	HCR	Continued advocacy on the impact to Employer Group Waiver Plans (EGWPs) with respect to S. 2543, the Prescription Drug Pricing Reduction Act of 2019, from last session, and H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act of 2021, which does not include a fix for Employer Group Waiver Plans (EGWPs). Continued education on the impact of changes to Medicare Part D restructuring for EGWP plans with House and Senate members, the pending Rebate Rule which has been stayed by the Biden Administration and its consequences to plan sponsors.	Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE	9999		0	0	2021-09-01T19:48:20.497000-04:00